Because of its value as a diagnostic biomarker for liver fibrosis, elucidation of the biological functions of CHI3L1 and potential mechanistic contribution to the development and progression of NASH-related inflammation and fibrosis are warranted. The gene discussed is CHI3L1; the disease is metabolic dysfunction-associated steatohepatitis.